Compare AMRX & FOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | FOUR |
|---|---|---|
| Founded | 2002 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.7B |
| IPO Year | 2018 | 2020 |
| Metric | AMRX | FOUR |
|---|---|---|
| Price | $13.08 | $44.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 22 |
| Target Price | $15.60 | ★ $79.05 |
| AVG Volume (30 Days) | 1.4M | ★ 1.4M |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.89 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | N/A | ★ $4,180,000,000.00 |
| Revenue This Year | $4.48 | $23.83 |
| Revenue Next Year | $7.13 | $14.30 |
| P/E Ratio | $68.18 | ★ $27.53 |
| Revenue Growth | N/A | ★ 25.50 |
| 52 Week Low | $7.07 | $39.61 |
| 52 Week High | $15.42 | $107.16 |
| Indicator | AMRX | FOUR |
|---|---|---|
| Relative Strength Index (RSI) | 57.73 | 52.19 |
| Support Level | $12.45 | $43.56 |
| Resistance Level | $13.64 | $51.14 |
| Average True Range (ATR) | 0.34 | 2.16 |
| MACD | 0.07 | 0.35 |
| Stochastic Oscillator | 88.00 | 87.03 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Shift4 Payments Inc is an independent provider of software and payment processing solutions in the U.S., expanding internationally. Its payments platform offers integrated products and services across in-store, online, mobile and tablet-based channels, including end-to-end payment processing, merchant acquiring services, a proprietary omni-channel gateway, eCommerce capabilities, and reporting tools. The company distributes its services through internal sales teams and partners, including independent software vendors (ISVs) and value-added resellers (VARs). Revenue is predominantly recurring, derived mainly from processing fees and subscription revenue from POS software, business intelligence tools and other technology solutions. The company derives maximum revenue from the United States.